Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Palbociclib
Sponsor: Jules Bordet Institute